Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment-Reference-Cited by-同舟云学术

Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment

Published:2020-12-17 Issue:1 Volume:21 Page:9-27
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Marra Fiona^ORCID,Smolders Elise J.,El-Sherif Omar,Boyle Alison,Davidson Katherine,Sommerville Andrew J.,Marzolini Catia,Siccardi Marco,Burger David,Gibbons Sara,Khoo Saye,Back David

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40268-020-00333-0.pdf

Reference109 articles.

1. Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephro., 2020.

2. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428–30.

3. Marcellin P, Kutala BK. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 2018;38(Suppl 1):2–6.

4. Qi X. COVID-19 in patients with pre-existing cirrhosis (COVID-Cirrhosis-CHESS2002): a multicentre observational study. 2020. https://clinicaltrials.gov/ct2/show/NCT04329559.

5. Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497–506.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial;Clinical Infectious Diseases;2024-06-24

2. Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID‐19;Fundamental & Clinical Pharmacology;2024-02-11

3. A narrative review on adverse drug reactions of COVID-19 treatments on the kidney;Open Medicine;2024-01-01

4. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response;Management, Body Systems, and Case Studies in COVID-19;2024

5. COVID‐19‐associated liver injury: Adding fuel to the flame;Cell Biochemistry and Function;2023-11-10